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Prognostic factors predicting a 
fatal outcome in hiv-negative 
children with neurotuberculosis
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AbstrAct
Objective: To identify prognostic factors predicting a fatal outcome in HIV-negative 
children with neurotuberculosis based on clinical, epidemiological, and laboratory findings. 
Method: The clinical records of all in-patients diagnosed with neurotuberculosis from 
1982 to 2005 were evaluated retrospectively. The following prognostic parameters were 
examined: gender, age, close contact with a tuberculosis-infected individual, vaccination for 
bacillus Calmette-Guérin, purified protein derivative (PPD) of tuberculin results, concomitant 
miliary tuberculosis, seizures, CSF results, and hydrocephalus. results: One hundred forty-
one patients diagnosed with neurotuberculosis were included. Seventeen percent of the 
cases resulted in death. The factors that were correlated with a negative outcome included 
lack of contact with a tuberculosis-infected individual, negative PPD reaction, coma, and 
longer hospitalisation time. A multiple logistic regression analysis was performed to identify 
which of these factors most often resulted in death. conclusion: Coma at diagnosis, lack of 
tuberculosis contact, and a non-reactive PPD were the most important predictors of fatality 
in patients with neurotuberculosis.
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Fatores prognósticos de letalidade da neurotuberculose em crianças HIV-negativas
resuMO
Objetivo: Identificar elementos prognósticos para a letalidade da neurotuberculose 
na criança, a partir das manifestações clínicas, dados epidemiológicos e laboratoriais. 
Método: Registros de pacientes internados durante o período de 1982 a 2005 foram 
retrospectivamente avaliados. Os elementos prognósticos considerados foram: sexo, 
idade, história de contato íntimo com indivíduo com tuberculose, vacinação com o bacilo 
de Calmette-Guérin (BCG), teste tuberculínico (PPD), concomitância de tuberculose miliar, 
convulsões, resultados da análise do LCR e presença de hidrocefalia. resultados: 141 
pacientes com diagnóstico de neurotuberculose foram incluídos. Dezessete por cento 
dos pacientes foram a óbito. Os fatores associados ao óbito foram história negativa 
de contágio, ausência de reatividade ao teste de PPD, coma e tempo de internação 
prolongado. Análise por regressão logística múltipla foi usada para investigar as relações 
entre os elementos prognósticos e o desfecho óbito. conclusão: Os fatores prognósticos 
na previsão de óbito nos pacientes com neurotuberculose foram a presença de coma no 
momento do diagnóstico, a ausência de história de contágio e a ausência de reação ao PPD.
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Tuberculosis remains one of the most 
severe infectious diseases and more than 
eight million new cases are diagnosed 
worldwide each year. The disease is espe-
cially prevalent in developing countries af-
fected by poverty, malnutrition, and over-
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population1. In addition, the human immunodeficiency 
virus (HIV) has caused a resurgence of tuberculosis2,3.
According to the World Health Organisation, 22 
countries are responsible for more than 80% of tubercu-
losis cases. Among these countries, Brazil occupies the 
14th position, reporting more than 60 cases per 100,000 
inhabitants, 50 million infected people, 92,000 new cas-
es, and 8,400 deaths annually4.
Although pulmonary tuberculosis is more frequent, 
neurotuberculosis is considered a more severe form be-
cause even when treated, it often leads to death or neu-
rological sequelae5,6.
Important prognostic indicators of neurotuberculo-
sis include age (especially very young or old individuals), 
clinical stage at diagnosis, presence of neurological defi-
cits, presence of other forms of tuberculosis, presence of 
other diseases, malnutrition, seizures, and resistance to 
tuberculosis treatment5.
However, the clinical manifestations of tuberculosis 
differ in children and adults. In children, a closed caseous 
lesion is commonly the primary infection. Children also 
present extrapulmonary cases more frequently and exhib-
it a higher incidence of miliary dissemination7.
This study aims to identify prognostic factors that may 
predict a fatal outcome in HIV-negative children who suf-
fer from tuberculosis based on clinical, epidemiological, 
and laboratory findings.
METHOD
The study was performed at the Nossa Senhora da 
Glória Children’s Hospital in Vitória ES, Brazil. The clin-
ical records of all in-patients diagnosed with neurotuber-
culosis from 1982 to 2005 were evaluated retrospectively. 
We used the diagnostic criteria for neurotuberculosis pro-
posed and validated by Ahuja et al.8 and Doerr et al.9.
Patients with a definitive or probable diagnosis of neu-
rotuberculosis were included5. A definitive diagnosis was 
defined by either the presence of alcohol acid-resistant 
bacillus in the cerebrospinal fluid (CSF), a positive cul-
ture for Mycobacterium tuberculosis, or a conclusive post-
mortem examination. A probable diagnosis was defined 
by neurologically abnormal signs and symptoms accom-
panied by two or more of the following conditions: [A] 
CSF with pleocytosis and predominance of lymphocytes 
(characteristic of the neutrophilic dominance of early tu-
berculosis) without evidence of other infection; [B] pre-
vious or concomitant contact (either intradomiciliary or 
otherwise significant) with a tuberculosis-infected indi-
vidual, or a positive culture for Mycobacterium tubercu-
losis from any part of the body other than the central ner-
vous system; [C] radiological evidence of pulmonary tu-
berculosis; [D] a reactive tuberculin test without a vaccine 
scar; and [E] a cranial computed tomography (CT) scan 
compatible with tuberculous meningoencephalitis (i.e., a 
CT showing two or more of the following features: exu-
dates in the basal cisterns or sylvian sulcus, hydrocepha-
lus, tuberculomas, infarcts, or gyral enhancement). Since 
1986, when ELISA for HIV becomes available to us, all 
patients were tested for HIV infection and positive cas-
es were excluded.
The following prognostic parameters were exam-
ined: gender, age, previous or concomitant contact with 
a tuberculosis-infected individual (either intradomicili-
ary or other prolonged contact), vaccination for bacillus 
Calmette-Guérin (BCG) (this immunisation is required 
in Brazil and can be confirmed by the presence of a vac-
cine scar on the right deltoid or by cross-referencing with 
a vaccine register), presence of tuberculin purified protein 
derivative (PPD), concomitant miliary tuberculosis, sei-
zures, and hydrocephalus. A CSF analysis was also per-
formed, and the results were statistically analyzed.
To classify the severity of the disease in our patients, 
we used the clinical stages defined by the British Medical 
Research Council (BMRC): stage I - patients with gener-
al symptoms (fever, anorexia, headache, and vomiting); 
stage II - patients with meningeal irritation accompanied 
by a diminished level of consciousness; and stage III - pa-
tients with coma, decortication, or descerebration5.
RT23 PPD tuberculin was used and applied following 
the Mantoux technique via an intradermic route in the 
middle third of the anterior forearm. The dose was 0.1 ml, 
which is equivalent to 2 TU (tuberculin units). The larg-
er transverse diameter of the indurate palpable area was 
measured with a millimetre ruler 72 to 96 hours after tu-
berculin application. The result was recorded in millime-
tres: up to 4 mm (non-reactive); 5 to 9 mm (weak reac-
tive); 10 mm or more (strong reactive)10.
A Chi-square (c2) or Fisher statistical test was used 
to compare categorical prognostic factors between sur-
viving and deceased patients. A Student’s t-test (t) was 
used to compare the mean values of the continuous mea-
surements. A multiple logistic regression analysis was 
used to investigate the relationship between fatality and 
the prognostic factors that were found to be significant in 
the univariate analysis. Missing data were excluded, and 
outliers were not removed from the model. The odds ra-
tios (OR) with 95% confidence intervals (CI) are report-
ed. All tests were two tailed; a p-value<0.05 was consid-
ered to indicate a statistically significant difference. All 
statistical analyses were conducted on a personal com-
puter with the SPSS for Windows (version 11.5.1) soft-
ware package.
The hospital ethics commission of the Federal Univer-
sity of São Paulo and the technical directive department 
of the Nossa Senhora da Glória Children’s Hospital ap-
proved this study under registration number 0796/07.
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RESULTS
One hundred forty-one cases of children with neuro-
tuberculosis from 1982 to 2005 were reviewed. A defin-
itive diagnosis was established in twenty-three patients 
(16%); the remaining cases (84%) were children with a 
probable diagnosis.
The incidence age varied from 3 to 156 months (medi-
an 24 months). Among the 141 cases, 87 (62%) were boys, 
68 (48%) had been previously immunised with the BCG 
vaccine, 109 (77%) reported either an intradomiciliary or 
other significant contact with a tuberculosis-infected pa-
tient, and 27 (19%) presented concomitant miliary tuber-
culosis. The mean length of hospitalisation varied from 2 
to 270 days (median 60 days). The main clinical findings 
are listed in Table 1.
CSF analysis
The Koch bacillus was identified in the CSF of 23 
(16%) of the children. Of those, 9 (39%) presented a pos-
itive CSF culture, 9 (39%) presented a positive direct ex-
amination, and 5 (22%) presented positive results using 
both methods.
The mean±SD of the CSF protein, glucose, and cell 
count was 143.2 (17-1034) mg/100 ml, 34.9 (0-100) 
mg/100 ml, and 325.1 (10-5120) cells/mm3, respectively. 
A hundred-fourteen (81%) patients presented CSF pro-
tein readings of above 40 mg/100 ml and 109 (77%) pre-
sented CSF glucose readings lower than 50 mg/100 ml.
Neuroimaging
Computed tomography scans were performed on 62 
(44%) of the patients. Among these scans, 54 (87%) dis-
closed abnormalities. Hydrocephalus was the most preva-
lent abnormality (79% of the scans), followed by infarct ar-
eas (18%) and tuberculomas (16%). Interestingly, isolated 
tuberculomas were found in 11 (17.7%) of the scans, and 
isolated infarct areas were found in 2 (3%). One patient pre-
sented with concomitant tuberculomas and infarct areas.
PPD test
The PPD test was performed during the first week of 
hospitalisation. Of the 141 patients, 69 (49%) of the pa-
tients were non-reactive, 14 (10%) were weakly reactive, 
and 58 (41%) were strongly reactive. 
Among the children with previous immunisation, the 
PPD test reactivity did not vary significantly: 70 (50%) 
were non-reactive, 18 (13%) were weakly reactive, and 53 
(37%) were strongly reactive (c2(2)=6.0; p=0.050).
Table 1. Frequency of the signs and symptoms of neurotuberculosis 
patients at the time of admission.
Signs and symptoms %
Fever 96
Nuchal rigidity 79
Vomiting 63
Spasticity 52
Drowsiness 50
Anorexia 49
Seizures 46
Apathy 45
Cough 38
Headache 36
Weight loss 33
Irritability 32
Cranial nerve palsies 30
Stupor 19
Slow photomotor reflex 18
Diarrhoea 16
Coma 13
Constipation 9
Table 2. Comparison of prognostic factor frequencies in surviving and deceased neurotuberculosis 
patients. Factors include previous BCG immunisation, positive tuberculosis contact, miliary tuberculosis, 
PPD reactivity, CT abnormalities, coma, epileptic seizures, and CSF polymorphonuclear predominance. 
Prognostic factors n Survivors (%) Deceased (%) c2 (1) p 
BCG immunisation 141 46 58 1.18 0.277
Contact 141 80 58 5.38 0.020*
Miliary tuberculosis 141 20 12 – 0.569+
PPD reactivity 128 54 29 4.61 0.032*
CT abnormalities 62 85 100 – 0.590+
Coma 141 6 47 28.40 <0.001*
Seizures 141 43 62 3.13 0.077
PMN predominance 140 27 29 0.06 0.807
*Significant; +Fisher statistical test; BCG: bacillus Calmette-Guérin; PPD: purified protein derivative; CSF: cerebrospinal fluid; 
PMN: polymorphonuclear; CT: computed tomography.
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Lethality
Twenty-four (17%) patients died. Tables 2 and 3 com-
pare the prognostic parameters of surviving and deceased 
patients.
The factors associated with a negative outcome were 
a negative history of contact with a tuberculosis-infect-
ed individual, a negative PPD reaction, coma, or a longer 
hospitalisation time.
A multiple logistic regression analysis was performed 
to identify which of the preceding factors most often re-
sulted in fatalities (Table 4). We found that coma at the 
time of hospitalisation and a negative tuberculosis con-
tact history were the factors most strongly correlated with 
fatality.
The difference in the proportion of deceased patients 
between the definite (13%) and probable (18%) cases was 
not significant (Fisher exact test, p=0.765).
DISCUSSION
We found that coma at the time of admission, a nega-
tive tuberculosis contact history, and a non-reactive PPD 
were most commonly associated with fatalities in neuro-
tuberculosis patients.
Our series had a low percentage of fatalities (17%), a 
result that is similar to data from Mahadevan et al. (16%)11 
and Lee et al. (10%)7. In our study, most of the patients 
were in clinical stages I or II as defined by the BMRC scale, 
which may explain the low percentage of lethal cases. 
Despite these results, the high lethality of neurotu-
berculosis is what makes it more severe than other forms 
of tuberculosis12. Some authors have tried to identify the 
prognostic factors of neurotuberculosis13-15. The level of 
consciousness at the time of admission or at the time that 
a specific therapy is established is the main prognostic 
factor that predicts disease lethality and sequelae16,17. In 
our study, more than 60% of the 24 patients who died 
were in coma when hospitalised.
Among our patients, 77% had a history of close con-
tact with an individual who was a confirmed tuberculo-
sis sufferer. In other studies, the history of close contact 
with tuberculosis varies widely from 20 to 75%18-20. Ab-
sence of close contact with a tuberculosis-infected indi-
vidual, however, tends to be strongly correlated with fatal-
ities. In our study, 15% of the patients had a negative his-
tory of close contact and 30% of these patients eventually 
died. The absence of close contact may be related to high-
er fatalities because of a delay in establishing an appro-
priate treatment protocol. More than half of our patients 
began treatment during the first few days of hospitalisa-
tion, most of whom reported a positive epidemiological 
history that caused us to suspect tuberculosis. Another 
explanation is that these patients could have some kind 
of immunological deficient mechanisms, being more sus-
ceptible to develop neurotuberculosis, even with a small 
inoculus.
Molavi et al.19 and Hosoglu et al.21, over a decade later, 
addressed the importance of contact history as an impor-
tant and useful epidemiological tool for the early diagno-
sis of tuberculosis. Their reports, however, failed to cor-
relate this data with the patient’s prognosis. While a his-
tory of close contact did reduce the time between diag-
nosis and treatment, in our experience this history is of-
Table 3. Comparison of the prognostic factor mean values among surviving and deceased neurotuberculosis patients. 
Prognostic factors
(mean ± SD)
95% Ci (mean difference) t DF pSurvivors Deceased
Age 43.8 45.8 48.4 44.5 –15.2 to 24.4 0.5 139 0.646
Length of hospitalisation (days) 45.7 53.9 72.0 49.4 4.0 to 48.5 2.3 139 0.021*
Cellularity 283.6 379.6 333.7 555.9 –185.2 to 285.4 0.4 138 0.674
CSF protein 143.6 146.2 143.1 150.7 –67.0 to 66.0 0.0 138 0.987
CSF glucose 30.1 19.6 35.9 22.5 –3.9 to 15.6 1.2 138 0.238
*Significant; SD: standard deviation; CI: confidence interval; DF: degrees of freedom; CSF: cerebrospinal fluid.
Table 4. Likelihood of death based on results from the multiple logistic regression analysis using the prognostic factors as independent 
variables. 
Prognostic factors B SE Wald c2 OR 95% Ci    (OR) p
Coma –2.11 0.53 15.65 0.12 0.04 to 0.35 <0.001*
Hospitalisation time –0.01 0.01 3.45 0.99 0.97 to 1 0.063
Absence of contact 1.24 0.58 4.6 3.47 1.11 to 10.82 0.032*
Absence of PPD reactivity 0.81 0.5 2.59 2.25 0.84 to 6.05 0.108
*Significant; n deceased: n survivors=21:107; SE: standard error; c2: chi-square; CI: confidence interval; OR: odds ratio; PPD: purified protein derivative.
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ten difficult to obtain from the patients or their relatives 
because of the continuing stigma surrounding tubercu-
losis and due to ignorance about the disease.
In our study, a non-reactive PPD was found in 63% of 
the patients and this was shown to have a negative im-
pact on patient outcomes. A non-reactive PPD would not 
be unusual if the disease were in an advanced stage, when 
patients present severe cellular immunity impairment22. 
This may also be explained by a previous deficiency of im-
mune mechanisms. The correlation between a negative 
prognosis and PPD insensitivity may be a direct conse-
quence of a typical meningeal reaction failure23,24. Succi et 
al.25 found that, among 111 children with neurotubercu-
losis, those with a consistently negative PPD results had 
more extensive neurological involvement.
CT scans were performed on only 44% of the patients 
because many of them were treated between 1982 and 
1990, a decade when this resource was largely unavail-
able in our centre. However, every patient in our study 
who died presented an abnormal CT examination that 
suggested hydrocephalus, infarct areas, or tuberculomas. 
Tan et al.26 examined a group of 18 patients with neuro-
tuberculosis and found that the presence of hydroceph-
alus was the only factor associated with a negative prog-
nosis; however, this prognosis was also correlated with a 
more advanced disease stage. 
The high incidence of hydrocephalus in our series re-
flects the typical physiopathological presentation of neu-
rotuberculosis, which includes a blockage of CSF drain-
age-especially in the basal cisterns27. However, we found 
only a weak correlation between hydrocephalus and fatali-
ties, perhaps because our patients presented only mild hy-
drocephalus. Although hydrocephalus is a common fea-
ture of neurotuberculosis and is associated with a nega-
tive prognosis, early treatment can prevent the progres-
sion of ventricular dilatation28. If these patients had been 
diagnosed earlier, the prognosis could potentially have 
been better29.
The presence of seizures has also been correlated 
with eventual fatality. Paganini et al.30 reported that sei-
zures were an important predictor of fatal outcomes in 40 
children with tuberculosis. In this report, seizures were 
manifested late in the disease and were usually associated 
with more advanced stages of tuberculosis24. In our study, 
however, seizures were not related to death. Importantly, 
our study only evaluated symptoms after hospitalisation. 
In contrast with Paganini et al.30, who regarded seizure 
as a late manifestation of tuberculosis, our study found 
that, after hospitalisation, seizures could be present in 
any stage of the disease.
The presence of CSF alterations also failed to predict a 
negative prognosis. Succi et al.25 assessed the clinical evo-
lution of patients with different intensities of pleocytosis, 
concluding that CSF alterations increased the likelihood 
of fatality but noting that this correlation was not statis-
tically significant. In contrast, Singh et al.31 found that pa-
tients who presented protein concentrations above 200 
mg/dL, glucose lower than 20 mg/dL, and chlorides low-
er than 650 mg/dL exhibited a higher incidence of fatali-
ty. However, Singh et al. only included adult patients and 
failed to analyse their data for statistical significance.
In our study, the concomitance of miliary tuberculo-
sis was also not associated with fatality. Succi et al.25 con-
cluded that the presence of radiological alterations, which 
indicate the presence of miliary tuberculosis, did not in-
crease the likelihood of death. Our study used the same 
radiological criteria to determine the presence of miliary 
tuberculosis. It is possible that those patients who sur-
vived long enough to present an image that was detect-
able and indicated miliary dissemination had a stronger 
immune response. Thus, these patients exhibited a sur-
vival rate similar to those patients without miliary dis-
semination. In contrast, Paganini et al.30 reported that ex-
tra-meningeal foci of tuberculous meningitis were pre-
dictors of fatality. They hypothesised that the detection 
of extra-meningeal tuberculosis in neurotuberculosis pa-
tients may be an important tool for early diagnosis and 
may lead to a better prognosis.
Rodrigues et al.32 argued that BCG immunisation may 
protect children against the most severe forms of tuber-
culosis and result in a better prognosis. In our study, BCG 
immunisation did not affect the prognosis of neurotu-
berculosis. However, because all of the patients enrolled 
in our study already presented a severe form of the dis-
ease, we were unable to evaluate whether BCG immuni-
sation affects the prognosis of tuberculosis by protecting 
against the most severe forms. Interestingly, more than 
half of our patients had been immunised with BCG but 
still developed neurotuberculosis, calling into question 
the ability of the BCG vaccine to protect against severe 
forms of tuberculosis.
Our retrospective study was limited by the fact that 
neuroimaging was not performed with all patients. Ad-
ditionally, our diagnoses of tuberculosis were based on 
clinical criteria and we failed to secure microbiological 
confirmation.
In conclusion, coma at the time of hospitalisation and 
a negative history of close contact were the most impor-
tant prognostic factors indicating a fatal outcome among 
HIV-negative children with neurotuberculosis. Because 
it is difficult to diagnosis neurotuberculosis, any patient 
diagnosed with an infectious disease of unknown aetiolo-
gy and presenting neurological symptoms should be pro-
actively tested for tuberculosis.
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